Antisaccadic Effects of a Dopamine Agonist as Add-On Therapy in Advanced Parkinson’s Patients

Publisher： Karger

E-ISSN： 1423-0224|42|4|202-206

ISSN： 0302-282x

Source： Neuropsychobiology, Vol.42, Iss.4, 2000-11, pp. : 202-206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bupropion as Add-On Strategy in Difficult-to-Treat Bipolar Depressive Patients

By  

Neuropsychobiology, Vol. 45, Iss. 1, 2002-03 ,pp. : 33-36

Karger

Access to resources Recommend Favorite

The Association between Disease Severity and Sleep-Related Problems in Patients with Parkinson’s Disease

By  

Neuropsychobiology, Vol. 46, Iss. 2, 2002-10 ,pp. : 90-96

Karger

Access to resources Recommend Favorite

A Fetal Risk Factor for Parkinson’s Disease

By  

Developmental Neuroscience, Vol. 26, Iss. 1, 2004-10 ,pp. : 11-23

Karger

Access to resources Recommend Favorite

Coexisting Parkinson’s and Wilson’s Disease: Chance or Connection?

By  

Canadian Journal of Neurological Sciences, Vol. 44, Iss. 2, 2016-11 ,pp. : 215-218

Cambridge University Press

Access to resources Recommend Favorite

Deep Brain Stimulation Target Selection for Parkinson’s Disease

By  

Canadian Journal of Neurological Sciences, Vol. 44, Iss. 1, 2016-03 ,pp. : 3-8

Cambridge University Press

Access to resources Recommend Favorite